TONYE LAWSON: Open Payments
NPI 1235779828 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| PFIZER INC. | 3 | $69 |
| Amgen Inc. | 1 | $35 |
| Inspire Medical Systems, Inc. | 2 | $32 |
| W. L. Gore & Associates, Inc. | 1 | $27 |
| Boston Scientific Corporation | 1 | $24 |
| Novo Nordisk Inc | 1 | $24 |
| Medtronic, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: LEQVIO, Kerendia, VYNDAQEL, INSPIRE, GORE CARDIOFORM Septal Occluder, LUX-Dx Insertable Cardiac Monitor, Wegovy, LINQ II.
Industry payments across TX — which companies pay providers there.
